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Abstract 7 
This article presents a microbiological system composed of a “BT” bioassay (Beta-8 
lactams and Tetracyclines) and a “QS” bioassay (Quinolones and Sulfonamides). The 9 
“BT” bioassay contains spores of Geobacillus stearothermophilus, bromocresol purple 10 
and cloramphenicol in a culture medium (incubation time: 2.45 h), while the “QS” 11 
bioassay uses spores of Bacillus subtilis, trifenyltetrazolium - toluidine blue and 12 
trimethoprim in a suitable culture medium (incubation time: 5.5 h). The detection 13 
capability (CCβ) of 27 antimicrobial agents in ovine milk were determined by logistic 14 
regression models. Thus, the “BT” bioassay detects amoxycillin, ampicillin, penicillin 15 
"G", cloxacillin, oxacillin, cephalexin, cefoperazone, ceftiofur, chlortetracycline, 16 
oxytetracycline, tetracycline, neomycin, gentamicin and tylosin, while “QS” bioassay 17 
detects: ciprofloxacin, enrofloxacin, marbofloxacin, sulfadiazine, sulfadimethoxine, 18 
sulfamerazine, sulfamethazine, sulfamethoxazole, sulfathiazole, erythromycin, 19 
lincomycin and spiramycin at levels close to their respective Maximum Residue Limits. 20 
The simultaneous use of both bioassays detects a large number of antibiotics in milk 21 
given each method’s adequate complementary sensitivity. 22 
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In recent years, increased use of antibiotics to treat mastitis and other diseases of small 25 
ruminants was observed due to the intensification of milk production (Buswell and 26 
Barber, 1989). 27 
The presence of antibiotic residuals in milk poses a potential risk for the consumers as 28 
they may cause allergic type reactions, and may interfere with intestinal flora and the 29 
development of resistance to antibiotics (Demoly and Romano, 2005; Dewdney et al., 30 
1991; Currie et al., 1998; Wilke et al., 2005). Furthermore, antibiotic residues in milk 31 
can lead to important losses in fermented products, such as cheese-making (Berruga et 32 
al., 2007; Brady and Katz, 1988; Mourot and Loussourorn, 1981; Packham et al., 2001). 33 
Therefore, monitoring antibiotic residues is very important in controlling food safety. 34 
For these reasons, several control authorities such as the European Union (Council 35 
Directive, 2009) and Codex (Codex Alimentarius, 2009) determine the Maximum 36 
Residue Level (MRL) for the presence of specified veterinary residues in milk. 37 
To this end, several commercially available tests have been developed for the swiftly 38 
and precisely detect of the presence of antibiotic residuals in milk (Toldra and Reig, 39 
2006). Many of the screening tests are based on the inhibition of G. stearothermophilus 40 
subsp. calidolactis caused by the presence of drug residues. However, this bacteria does 41 
not have sensitivity to detect many of the antibiotics used to treat livestock such as 42 
quinolones (Montero et al., 2005), spiramycin, lincomycin (Linage et al., 2007), 43 
erythromycin and streptomycin (Molina et al., 2003; Althaus et al., 2002, 2003).  44 
In addition, rapid methods are specific to small groups of antibiotics, but cannot 45 
increase the number of molecules to be controlled (Althaus et al., 2001; Roca et al., 46 
2009).  47 
Given the absence of a single ideal screening method that is sensitive to a large number 48 
of antimicrobial agents in ovine milk, the objective of this study was to evaluate the 49 
application of a microbiological system that uses two bacteria test (G. 50 
stearothermophilus and B. subtilis) to detect a larger number of antibiotics in milk and 51 
to ensure consumer food safety. 52 
2. Materials and methods 53 
2. 1. Preparation of microplates 54 
The “BT” bioassay (G. stearothermophilus): Plate Count Agar (Difco

, Ref. 247940) 55 
culture medium (6.25 g/l casein peptone, 2.25 g/l yeast extract and 15 g/l agar) fortified 56 
with glucose (10 g/l; Sigma

, Ref 158968) was used. The culture medium was sterilized 57 
to 121ºC for 15 min. Then, it was cooled to 501ºC and the pH was adjusted to a value 58 





, Ref. 1.11499), bromocresol purple indicator 60 
(0.05 mg/l, Mallinckrodt
®
, Ref. 2090) and chloramphenicol (400 g/ml, Sigma 61 
Aldrich
®
, Ref. C0378) were added in accordance with Nagel et al. (2009). 62 
The “QS” bioassay (B. subtilis): Müeller Hinton (38 g/l, Biokar Diagnostics
®
, Ref. 63 
BK048HA) culture medium fortified with glucose (10 g/l; Sigma Aldrich
®
, Ref. 64 
G7528), trimethoprim (400 mg/l; Sigma Aldrich
®
, Ref. T7883), 2,3,5-65 
tripheyltetrazolium chloride (150 mg/l; Sigma Aldrich
®
, Ref. T8877) and toluidine blue 66 
(15 mg/l; Sigma Aldrich
®
, Ref. 198161) was employed. Once prepared, the culture 67 
medium was inoculated with the spore’s suspension of B. subtilis BGA (Merck
®
, Ref. 68 
1.10649) under sterile conditions in accordance with Nagel (2009). 69 
Then 100 l of the culture medium were added to each individual well of microtiter 70 
plate using an electronic pipette (Eppendorf Research
®
 Pro). Next, these microplates 71 
were sealed with aluminized film and conserved at 4ºC until use. 72 
2.2. Animals and ewe milk samples  73 
The ewes were fed with natural pastures of Melilotus albus, Trifolium repens and 74 
Lolium multiflorum, during the lactation period. Individual samples were collected from 75 
40 Pampinta (Milchschaff x Corriedale) ewes from the experimental farm at the Escuela 76 
de Agricultura Ganadería y Granja of the Universidad Nacional del Litoral in Argentina 77 
(south latitude: 31° 28', west longitude: 60° 55'). Animals did not receive any 78 
antimicrobial substances, and the samples were collected from ewes in the period 79 
between 30 and 90 days postpartum, from the recorder jar during morning milking and 80 
placed in 100 ml sterile plastic containers. Milk samples were kept at 4º C throughout 81 
the experiment.  82 
2.3. Antimicrobial solutions and spiked samples 83 
Drugs for the preparation of antimicrobial solutions were stored and handled according 84 
to the manufacturers' instructions before use. All the dilutions were prepared in 10 mL 85 
volumetric flasks at the time when analyses were carried out to avoid possible 86 
inconvenience due to instability. Antimicrobial solutions were prepared from the 87 
respective stock solution in a single step using antimicrobial-free milk (IDF, 2002), as 88 
determined by the “BT” and “QS” bioassays. 89 
The dose-response curves of the antimicrobial agents were established in line with the 90 
Codex Alimentarius guidelines (Codex Alimentarius, 2010). To this end, 8 91 
concentrations were prepared with different levels of each drug (Table 1). For each 92 
concentration, 24 replicates were prepared using antibiotic-free ovine milk samples 93 
obtained from individual animals. Then, 50 l milk samples were added to the 94 
individual wells of the “BT” and “QS” Bioassays. Plates were sealed with adhesive 95 
bands and incubated at 641ºC for 2.5 h (“BT” Bioassay) and 401ºC for 5.5 h (“QS” 96 
Bioassay) according to the colour change of the negative samples. Visual interpretation 97 
was carried out by 3 qualified individuals and evaluated as “negative” (BT” bioassay: 98 
yellow and “QS” bioassay: rose) or “positive” (BT” bioassay: purple and “QS” 99 
bioassay: blue). For the statistical calculations, those visual results that presented at 100 
least 2 similar interpretations were considered. 101 
2.3. Detection capability (CCβ) and statistical analysis 102 
To determine the detection capability (CCβ), 8 betalactams (amoxycillin, ampicillin, 103 
penicillin "G", cloxacillin, oxacillin, cephalexin, cefoperazone, ceftiofur), 3 104 
aminoglycosides (gentamicina, neomycin, streptomycin), 4 macrolides (erythromycin, 105 
lincomicin, tylosin, spiramycin), 3 quinolones (ciprofloxacin, enrofloxacin, 106 
marbofloxacin), 6 sulfonamides (sulfadiazine, sulfadimethoxine, sulfamerazine, 107 
sulfamethazine, sulfamethoxazole, sulfathiazole) and 3 tetracyclines (chlortetracycline, 108 
oxytetracycline, tetracycline) were analyzed according to Codex Alimentarius 109 
guidelines (Codex Alimentarius, 2010). 110 
The results were obtained using the SAS
®
 Logistic procedure (SAS
®
, 2001). The logistic 111 
regression model was also used to calculate the detection limits, as follows: 112 
     Lij = logit [Pij] = 0 + 1 [A]i + ij  (1) 113 
Where: Lij = lineal logistic model; [Pij] = logit [Pp/(1-Pp)]: the probability of a “positive” 114 
response / probability of a “negative” response); 0, 1 = the coefficients estimated for the 115 
logistic regression models; [A]i = antimicrobial concentration. ij = residual error. The 116 
concordance coefficient (SAS
®
, 2001) was applied as a rank correlation between the 117 
observed responses and the predicted probabilities. 118 
The CCβ were estimated as concentrations at which 95% of the positive results (Codex 119 
Alimentarius, 2010). 120 
3. Results and discussion 121 
Table 2 shows the results obtained by applying the logistic regression model to the 122 
visual interpretations of the “BT” and “QS” bioassays for the 27 antimicrobials 123 
analyzed in sheep´s milk. 124 
The “1” parameters indicate the slopes of the dose-response curves. Therefore, high 125 
values of this coefficient show a good sensitivity of the bacteria test to detect a 126 
particular antibiotic in milk.  127 
The “BT” bioassay presents high “1” coefficients values to beta-lactam antibiotics, 128 
tetracyclines, tylosin and neomycin, while the “QS” bioassay offers high values for this 129 
coefficients for most beta-lactams (except cloxacillin, cefoperazone and ceftiofur
®
), 130 
macrolides, quinolones and sulfonamides. 131 
The high “1” coefficients values, which use G. stearothermophilus for the detection of 132 
tylosin and beta-lactam antibiotics in ovine milk, were indicated with the BRT
®
 AiM 133 
(Molina et al., 2003), Delvotest
®
 SP (Althaus et al., 2002), Charm Blue-Yellow (Linage 134 
et al., 2007) and Eclipse
®
 100ov (Montero et al., 2005) methods. In addition, the last 135 
two methods presented high “1” parameters to sulfonamides. For the “QS” bioassay, 136 
Nagel (2009) indicated high “1” coefficients values when analyzing samples of cow's 137 
milk fortified with sulfonamide. 138 
The concordance coefficients obtained by applying of the logistic model were high for 139 
both bioassays. They fell between 70.49% for amoxicillin (“BT” bioassay) and 91.67% 140 
for sulfadimethoxine (“BT” bioassay), demonstrating the correct adjustment achieved 141 
by the logistic model. 142 
The detection capability (CCβ), calculated as concentrations which produce 95% of the 143 
positive results in dose-response curves (Codex Alimentarius, 2010), are summarized in 144 
Table 3. 145 
As regards the beta-lactam antibiotics analyzed, the “BT” bioassay presented similar 146 
CCβ to the respective MRLs (except cefoperazone), while the “QS” bioassay detected 147 
only to penicillin residues at the MRL level. The detection capability for the “BT” 148 
bioassay for beta-lactams were similar to the values calculated for BRT
®
 AiM 149 
(CCβAmoxicillin = 6 g/l, CCβAmpicillin = 6 g/l, CCβCloxacillin = 51 g/l, CCβPenicillin = 2 g/l, 150 
CCβCephalexin = 270 g/l, CCβCefoperazone  = 92 g/l and CCβCeftiofur  = 120 g/l) for Molina et 151 
al. (2003), Eclipse
®
 100ov (CCβAmoxicillin = 7 g/l, CCβCloxacillin = 68 g/l, CCβPenicillin = 5 152 
g/l, CCβCephalexin = 115 g/l and CCβCefoperazone  = 110 g/l) for Montero et al. (2005) and 153 
Charm
®
 Blue-Yellow (CCβAmpicillin = 5-6 g/l, CCβCloxacillin = 33-42 g/l, CCβPenicillin = 3-4 154 
g/l, CCβCephalexin = 160-202 g/l, CCβCefoperazone  = 73-82 g/l and CCβCeftiofur  = 96-107 155 
g/l) for Linage et al. (2007), which also used G. stearothermophilus as the bacteria 156 
test. However, Althaus et al. (2002) indicated lower detection capability when using the 157 
Delvotest
®
 SP method with ovine milk samples (CCβAmoxicillin = 3 g/l, CCβAmpicillin = 2 158 
g/l, CCβCloxacillin = 18 g/l, CCβPenicillin = 1 g/l, CCβCephalexin = 40 g/l, CCβCefoperazone = 159 
20 g/l and CCβCeftiofur = 33 g/l). 160 
Of the three aminoglycosides analyzed, only neomycin residues were detected by the 161 
“BT” bioassay at levels close to the MRL (1500 g/l), while gentamycin must be 162 
present at higher concentrations (450 g/l) to be detected by this bioassay. Neither 163 
bioassay was able to detect streptomycin residues (5000 g/l for “BT” bioassay and 164 
4500 g/l for “SQ” bioassay). It is necessary to emphasize that the BRT
®
AiM (630 g/l 165 
of neomycin, 3700 g/l of gentamycin and 6000 g/l of streptomycin), Delvotest
®
 SP 166 
(2600 g/l of neomycin, 1200 g/l of gentamycin and 6100 g/l of streptomycin), 167 
Eclipse
®
 100ov (9100 g/l of neomycin, 3140 g/l of gentamycin and 10100 g/l of 168 
streptomycin) and Charm
®
 Blue-Yellow (444-542 g/l of neomycin, 355-382 g/l of 169 
gentamycin and 3063-3593 g/l of streptomycin) methods obtained appropriate 170 
detection capability  for neomycin (except Eclipse
®
 100ov), high ones for gentamicin, 171 
but proved inadequate for streptomycin in ovine milk according to Althaus et al. (2002), 172 
Linage et al. (2007), Molina et al. (2003) and Montero et al. (2005), respectively. 173 
For macrolides, Table 3 shows that the CC for the “QS” bioassay for erythromycin (60 174 
g/l), lincomycin (280 g/l), tylosin (140 g/l) and spiramycin (380 g/l) were slightly 175 
above their respective MRLs, indicating good sensitivity for B. subtilis for that family 176 
of antibiotics in milk. On the contrary, “BT” bioassay presents a detection capability for 177 
tylosin (100 g/l) closer to their MRL (50 g/l) if compared to the “QS” bioassay. The 178 
low sensitivity of G. stearothermophilus to detect erythromycin (630 g/l for BRT
®
 179 
AiM, 830 g/l for Delvotest
®
 SP, 750 g/l for Eclipse
®
 100ov, and 444-522 g/l for 180 
Charm
®
 Blue-Yellow) and spiramycin (18100 g/l for Eclipse
®
 100ov, and 1106-1346 181 
g/l
 
for Charm Blue-Yellow) was pointed out by those authors. 182 
Of the three quinolones tested, ciprofloxacin (160 g/l) and enrofloxacin (230 g/l) 183 
were detected by the “QS” bioassay at levels near their MRL (100 g/l), while 184 
marbofloxacin residues must be present in milk at a higher level (280 g/l) than the 185 
MRL (75 g/l) to be detected by this method. In contrast, the “BT” bioassay was not 186 
sensitive to these antibiotics because it presented high CC for ciprofloxacin (2280 187 
g/l), enrofloxacin (2770 g/l) and marbofloxacin (5540 g/l) in ovine milk. It is 188 
noteworthy that Montero, Althaus et al. (2005) reported high CC for ciprofloxacin 189 
(5100 g/l) and enrofloxacin (4000 g/l) when using the Eclipse
®
 100ov method to 190 
analyze ovine milk samples fortified with quinolones. Similarly, Linage et al. (2007) 191 
reported a wide range (41000-46000 g/l) for the enrofloxacin residues analyzed by the 192 
Charm
®
 Blue-Yellow method.  193 
Once again, these studies indicate that the use of these commercial methods containing 194 
G. stearothermophilus is inadequate to control quinolones residues in ovine milk, and 195 
that the use of another bacteria test (e.g., B. subtilis) is necessary. 196 
Regarding sulfonamides, Table 3 shows that the “QS” bioassay presented similar 197 
detection capability (CCβSulfadiazine = 157 g/l, CCβSulfadimethoxine = 136 g/l, CCβSulfamerazine = 198 
115 g/l, CCβSulfamethazine = 200 g/l, CCβSulfamethoxazole = 123 g/l and CCSulfathiazole = 122 199 
g/l) to the MRLs. However, the “BT” Bioassay did not provide good limits for this 200 
family of antibiotics because there was no trimethoprim in the culture medium (Nagel et 201 
al., 2009). 202 
These limits were similar to those reported for the Charm
®
 Blue-Yellow test 203 
(CCβSulfadimethoxine = 101-119 g/l; CCβSulfamethazine = 309-328 g/l, CCβSulfathiazole = 122-151 204 
g/l) by Linage et al. (2007), but were lower than the levels obtained for Eclipse
®
 100ov 205 
(CCβSulfadimethoxine = 170 g/l; CCβSulfamethazine = 750 g/l, and CCβSulfathiazole = 250 g/l) 206 
reported by Montero et al. (2005) when using G. stearothemophilus instead of B. 207 
subtilis. Nevertheless, Althaus et al. (2002) calculated lower detection capability 208 
(CCβSulfadiazine = 88 g/l and CCβSulfamethoxazole = 44 g/l) than those obtained in this work 209 
(Table 3) when analyzing ovine milk samples by the Delvotest
®
 SP method. 210 
To synthesize, the Figure 1 shows the detection pattern by the simultaneous 211 
implementation of "BT" and "QS" bioassays. This scale was constructed by applying 212 
the logarithmic transformation to CCβ/MRL for each antimicrobial. The interior, central 213 
and outer polygons corresponds to concentrations equivalent to 10 MRL, MRL, and 0.1 214 
MRL, respectively.  215 
This figure summarizes the adequate detection capability of the microbiological system, 216 
since most of the antibiotics have detection capability near their corresponding MRLs, 217 
with the exception of streptomycin. It is noted that the CCβ of the different antibiotics 218 
analyzed by this microbiological system are located close to central polygon (MRL). 219 
4. Conclusions 220 
The microbiological system consists of two bioassays using G. stearothermophilus and 221 
B. Subtilis, which can detect a large number of antibiotics in milk (beta-lactams, 222 
quinolones, sulfonamides, tetracyclines, erythromycin, lincomycin, neomycin, 223 
spiramycin and tylosin) if compared with other currently used microbiological methods. 224 
This improved detection of antibiotic residues is achieved by using two bacteria tests 225 
with complementary sensitivity to detect different antibiotics.  226 
Therefore, this microbiological system proves to be a valuable tool to control the quality 227 
of ovine milk. The implementation of this system with two bacteria tests enables a more 228 
rigorous control of antibiotic residues in milk and, consequently, helps protect 229 
consumers’ health. 230 
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Table 1 
Antimicrobial agent concentrations using for microbiological system. 
Antibiotics “BT” bioassay “QS” bioassay 
Betalactams   
Amoxycillin 0, 1, 2, 3, 4, 5, 6, 8 0, 1, 2, 4, 6, 8, 10, 12 
Ampicillin 0, 1, 2, 3, 4, 5, 6, 8 0, 5, 10, 20, 30, 40, 50, 60 
Cloxacillin 0, 10, 15, 20, 25, 30, 40, 60  0, 50, 100, 150, 200, 250,300, 400 
Oxacillin 0, 2, 5, 10, 15, 20, 25, 30 0, 25, 50, 100, 150, 200, 250, 300 
Penicillin “G” 0, 1.0, 1.5, 2.0, 2.5, 3.0, 4.0, 5.0 0, 1.0, 1.5, 2.0, 2.5, 3.0, 4.0, 5.0 
Cephalexin 0, 25, 50, 75, 100, 150, 200, 300 0, 25, 50, 100, 125, 150, 200, 300 
Cefoperazone 0, 50, 75, 100, 150, 200, 300, 400 0, 50, 100, 125, 150, 200, 300, 400 
Ceftiofur

 0, 25, 50, 75, 100, 150, 200, 300 0, 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.8* 
Aminoglycosides   
Gentamycin 0, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8* 0, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 1.0* 
Neomycin 0, 0.5, 1.0, 1.5, 2.0, 2.5, 3.0, 4.0* 0, 2, 3, 4, 5, 6, 7, 8* 
Streptomycin 0, 1, 2, 3, 4, 5, 6, 7* 0, 1, 2, 3, 4, 5, 6, 7* 
Macrolides   
Erythromycin 0, 0.05, 0.1, 0.15, 0.2, 0.25, 0.3, 0.4* 0, 10, 20, 30, 40, 50, 60, 70 
Lincomicin 0, 0.1, 0.15, 0.20, 0.25, 0.30, 0.40, 0.50* 0, 0.10, 0.15, 0.20, 0.25, 0.30, 0.40, 0.50* 
Tylosin 0, 25, 50, 75, 100, 125, 150, 200 0, 60, 80, 100 ,120, 140, 160, 180 
Spiramycin 0, 1, 2, 3, 4, 5, 6, 7* 0, 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7* 
Quinolones   
Ciprofloxacin 0, 1.0, 1.5, 2.0, 2.5, 3.0, 4.0, 5.0* 0, 50, 100, 150, 200, 250, 300, 400 
Enrofloxacin 0, 1.0, 1.5, 2.0, 2.5, 3.0, 4.0, 5.0* 0, 50, 100, 150, 200, 250, 300, 400 
Marbofloxacin 0, 2.0, 2.5, 3.0, 4.0, 5.0, 6.0, 7.0* 0, 50, 100, 150, 200, 250, 300, 400 
Sulphonamides   
Sulfadiazine 0, 10, 20, 30, 40, 50, 60, 80* 0, 50, 100, 200, 300, 400, 500, 600 
Sulfadimethoxine 0, 0.5, 0.8, 1.0, 1.3, 1.5, 2.0, 3.0* 0, 50, 100, 200, 300, 400, 500, 600 
Sulfamerazine 0, 10, 15, 20, 25, 30, 35, 40*  0, 50, 100, 200, 300, 400, 500, 600 
Sulfamethazine 0, 10, 20, 30, 40, 50, 60, 80* 0, 50, 100, 200, 300, 400, 500, 600 
Sulfamethoxazole 0, 5, 10, 15, 20, 25, 30, 35* 0, 50, 100, 200, 300, 400, 500, 600 
Sulfathiazole 0, 5, 10, 15, 20, 25, 30, 35* 0, 50, 100, 200, 300, 400, 500, 600 
Tetracyclines   
Clortetracycline 0, 50, 100, 150, 200, 300, 400, 500  0, 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7* 
Oxytetracycline 0, 25, 50, 75, 100, 150, 200, 300 0, 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7* 
Tetracycline 0, 25, 50, 75, 100, 150, 200, 300 0, 0.1, 0.2, 0.4, 0.6, 0.8, 1.0, 1.2* 
Units: g/l or *mg/l. 
Table 2 




“BT” Bioassay “QS” Bioassay 
0 1 C 0 1 C 
Betalactams       
Amoxycillin -4,950 2,123 70,49 -4,508 1,324 73,79 
Ampicillin -5,652 2,424 74,63 -6,055 0,723 88,29 
Cloxacillin -4,771 0,308 75,47 -5,406 0,036 66,95 
Oxacillin -3,064 0,402 73,02 -5,870 0,133 86,30 
Penicillin “G” -10,975 5,270 77,43 -10,320 3,707 71,34 
Cephalexin -3,237 0,048 79,14 -8,196 0,079 75,82 
Cefoperazone -11,619 0,084 75,72 -9,332 0,046 75,71 
Ceftiofur

 -11,421 0,125 88,82 -5,722 0,026 75,54 
Aminoglycosides       
Gentamycin -7,959 0,024 74,06 -14,330 0,026 77,02 
Neomycin -6,143 0,007 79,30 -16,381 0,003 78,27 
Streptomycin -8,749 0,002 86,32 -11,179 0,003 81,25 
Macrolides       
Erythromycin -9,732 0,056 78,86 -13,493 0,289 78,23 
Lincomicin -11,560 0,044 74,27 -12,445 0,055 78,87 
Tylosin -7,572 0,104 76,69 -132,074 0,951 89,08 
Spiramycin -8,380 0,003 77,42 -10,915 0,036 86,38 
Quinolones       
Ciprofloxacin -8,679 0,005 87,03 -22,162 0,152 88,26 
Enrofloxacin -9,809 0,005 86,33 -13,963 0,071 86,56 
Marbofloxacin -11,628 0,003 87,17 -11,672 0,051 75,76 
Sulphonamides       
Sulfadiazine -4,956 0,000 84,56 -5,850 0,056 80,64 
Sulfadimethoxine -16,157 0,001 91,67 -4,449 0,054 78,41 
Sulfamerazine -19,487 0,001 86,32 -4,494 0,065 76,74 
Sulfamethazine -20,267 0,001 92,65 -3,769 0,034 73,58 
Sulfamethoxazole -18,659 0,001 90,78 -5,183 0,066 79,15 
Sulfathiazole -20,429 0,001 89,46 -3,749 0,055 79,78 
Tetracyclines    
   
Clortetracycline -8,730 0,043 85,6 -9.254 0.026 82.4 
Oxytetracycline -6,611 0,074 72,65 -9,827 0,022 72,38 
Tetracycline -6,081 0,058 70,55 -8,053 0,013 76,67 
0, 1 = coefficients estimated for the logistic regression models; C: percentage concordance coefficients. 
 
Table 3 
Microbiological system detection capability (g/l) for antibiotics in milk. 
Antibiotics “BT” Bioassay 
a




Betalactams    
Amoxycillin 4 6 4 
Ampicillin 4 12 4 
Cloxacillin 25 232 30 
Oxacillin 15 66 30 
Penicillin “G” 3 4 4 
Cephalexin 128 141 100 
Cefoperazone 174 266 50 
Ceftiofur

 115 328 100 
Aminoglycosides    
Gentamycin 450 670 100 
Neomycin 1360 6700 1500 
Streptomycin 5000 4500 200 
Macrolides    
Erythromycin 230 60 40 
Lincomicin 330 280 150 
Tylosin 100 140 50 
Spiramycin 4280 380 200 
Quinolones    
Ciprofloxacin 2280 160 100 
Enrofloxacin 2770 230 100 
Marbofloxacin 5540 280 75 
Sulphonamides    
Sulfadiazine 53000 157 100 
Sulfadimethoxine 1300 136 100 
Sulfamerazine 23000 115 100 
Sulfamethazine 35000 200 100 
Sulfamethoxazole 17000 123 100 
Sulfathiazole 17000 122 100 
Tetracyclines    
Clortetracycline 271 470 100 
Oxytetracycline 129 570 100 
Tetracycline 154 840 100 
a 
Detection capabilities estimated as concentrations at which 95% of the positive results 
b 
MRLs (g/l).  
 
 
Fig. 1. Detection pattern by simultaneous implementation of BT and QS bioassays. Line 
1: 10 CCβ/LMR, Line 2: CCβ/LMR and Line 3: 0.1 CCβ/LMR. 
Note: The figure uses the lowest CCβ of antibiotics listed in Table 3.  
 
